The public float for DMAA is 5.87M and currently, short sellers hold a 0.13% ratio of that float. The average trading volume of DMAA on March 14, 2025 was 444.00K shares.
DMAA) stock’s latest price update
The stock price of Drugs Made In America Acquisition Corp (NASDAQ: DMAA) has jumped by 0.10 compared to previous close of 9.99.
DMAA’s Market Performance
The simple moving average for the past 20 days is 0.18% for DMAA’s stock, with a 0.18% simple moving average for the past 200 days.
DMAA Trading at 0.18% from the 50-Day Moving Average
After a stumble in the market that brought DMAA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.40% of loss for the given period.
During the last 5 trading sessions, DMAA fell by -0.10%, in comparison to the 20-day moving average. In addition, Drugs Made In America Acquisition Corp saw 0.40% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for DMAA
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.00.
Conclusion
In conclusion, Drugs Made In America Acquisition Corp (DMAA) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
